Keeping up with Change: The Delta Variant and PE/DVT

The PERT Consortium® kindly invites you to the webinar Keeping up with Change: The Delta Variant and PE/DVT. COVID-19 has a complex association with VTE, with data series suggesting higher levels of both pulmonary embolism and in situ pulmonary vascular thrombosis. What is the impact of this on your patient and what does the increased transmissibility of the Delta variant mean we should expect from VTE presentations this winter?


PERT Consortium® Quality Database

We are pleased to share with our friends and colleagues across the globe that: THE NATIONAL PERT CONSORTIUM HAS SUCCESSFULLY ENTERED 4000 UNIQUE PATIENTS INTO THE PERT CONSORTIUM QUALITY DATABASE. This is an incredible milestone and demonstrates a clear commitment from our members to advance the care of patients with Pulmonary Embolism.


Dedicated DOAC Trials for the Treatment of Pulmonary Embolism

The PERT Consortium invites you to listen to a series of podcasts moderated by past immediate president of PERT Consortium Victor Tapson, MD, and joined by Alex Spyropoulos, MD, as they discuss dedicated DOAC trials that evaluated the treatment of pulmonary embolism including initial treatment, early discharge of low risk PE patients, and extension of treatment to reduce the risk of recurrence.


The PERT consortium brings together clinicians who focus on pulmonary embolism to better the treatment of these patients

Learn More